• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

软组织肉瘤中 miRNAs 的失调。

Dysregulation of miRNAs in Soft Tissue Sarcomas.

机构信息

Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy.

Department of Sport Sciences and Wellness, University of Naples "Parthenope", 80100 Naples, Italy.

出版信息

Cells. 2024 Nov 8;13(22):1853. doi: 10.3390/cells13221853.

DOI:10.3390/cells13221853
PMID:39594601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11592554/
Abstract

MicroRNAs (miRNAs) are pivotal regulators of gene expression, influencing key cellular processes such as proliferation, differentiation, apoptosis, and metastasis. In the realm of sarcomas-a diverse group of malignant tumors affecting soft tissues and bone sarcomas-miRNAs have emerged as crucial players in tumorigenesis and tumor progression. This review delves into the intricate roles of miRNAs across various soft tissue sarcoma subtypes, including rhabdomyosarcoma, liposarcoma, leiomyosarcoma, synovial sarcoma, fibrosarcoma, angiosarcoma, undifferentiated pleomorphic sarcoma (UPS), and malignant peripheral nerve sheath tumor (MPNST). We explore how dysregulated miRNAs function as oncogenes or tumor suppressors, modulating critical pathways that define the aggressive nature of these cancers. Furthermore, we discuss the diagnostic and prognostic potential of specific miRNAs and highlight their promise as therapeutic targets. By understanding the miRNA-mediated regulatory networks, this review aims to provide a comprehensive overview of current research while pointing towards future directions for miRNA-based therapies. Our findings underscore the potential of miRNAs to transform the landscape of sarcoma treatment, offering hope for more precise, personalized, and effective therapeutic strategies.

摘要

微小 RNA(miRNAs)是基因表达的关键调节因子,影响增殖、分化、凋亡和转移等关键细胞过程。在肉瘤领域——一组影响软组织和骨肉瘤的多种恶性肿瘤——miRNAs 已成为肿瘤发生和肿瘤进展的关键参与者。本综述深入探讨了 miRNAs 在各种软组织肉瘤亚型中的复杂作用,包括横纹肌肉瘤、脂肪肉瘤、平滑肌肉瘤、滑膜肉瘤、纤维肉瘤、血管肉瘤、未分化多形性肉瘤(UPS)和恶性外周神经鞘瘤(MPNST)。我们探讨了失调的 miRNAs 如何作为癌基因或肿瘤抑制基因发挥作用,调节定义这些癌症侵袭性的关键途径。此外,我们讨论了特定 miRNAs 的诊断和预后潜力,并强调了它们作为治疗靶点的潜力。通过了解 miRNA 介导的调控网络,本综述旨在提供当前研究的全面概述,同时为 miRNA 为基础的治疗方法指明未来方向。我们的研究结果强调了 miRNAs 改变肉瘤治疗格局的潜力,为更精确、个性化和有效的治疗策略带来了希望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77b/11592554/f65bc39d8a8d/cells-13-01853-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77b/11592554/f65bc39d8a8d/cells-13-01853-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d77b/11592554/f65bc39d8a8d/cells-13-01853-g001.jpg

相似文献

1
Dysregulation of miRNAs in Soft Tissue Sarcomas.软组织肉瘤中 miRNAs 的失调。
Cells. 2024 Nov 8;13(22):1853. doi: 10.3390/cells13221853.
2
A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.一种选择性筛选平台揭示了人类软组织肉瘤队列中 microRNAs 的独特全球表达模式。
Lab Invest. 2016 Apr;96(4):481-91. doi: 10.1038/labinvest.2015.168. Epub 2016 Feb 15.
3
MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.不同组织学类型的软组织肉瘤中的 microRNAs:全面综述。
Int J Mol Sci. 2017 Sep 12;18(9):1960. doi: 10.3390/ijms18091960.
4
MicroRNA-mediated gene regulations in human sarcomas.微小 RNA 介导的人类肉瘤中的基因调控。
Cell Mol Life Sci. 2012 Nov;69(21):3571-85. doi: 10.1007/s00018-012-1127-x. Epub 2012 Aug 25.
5
The rare primary bone sarcomas: imaging-pathological correlation.罕见的原发性骨肉瘤:影像学-病理学相关性。
Skeletal Radiol. 2021 Aug;50(8):1491-1511. doi: 10.1007/s00256-020-03692-6. Epub 2021 Jan 7.
6
Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.脂肪肉瘤、横纹肌肉瘤、平滑肌肉瘤、滑膜肉瘤和血管肉瘤的当前分子与治疗进展。
J Oncol Pharm Pract. 2022 Apr;28(3):635-645. doi: 10.1177/10781552211073139. Epub 2022 Jan 19.
7
Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.软组织肉瘤的基因表达分析:恶性纤维组织细胞瘤的特征与重新分类
Mod Pathol. 2007 Jul;20(7):749-59. doi: 10.1038/modpathol.3800794. Epub 2007 Apr 27.
8
MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers.软组织肉瘤中的微小RNA:累积证据概述及其作为新型生物标志物的重要性
Biomed Res Int. 2014;2014:592868. doi: 10.1155/2014/592868. Epub 2014 Aug 4.
9
Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST.PSMA在高级别肉瘤(包括滑膜肉瘤、横纹肌肉瘤、未分化肉瘤和恶性外周神经鞘膜瘤)肿瘤新生血管中的表达。
Oncotarget. 2017 Jan 17;8(3):4268-4276. doi: 10.18632/oncotarget.13994.
10
microRNAs and Soft Tissue Sarcomas.微小RNA与软组织肉瘤
Adv Exp Med Biol. 2015;889:179-99. doi: 10.1007/978-3-319-23730-5_10.

引用本文的文献

1
Decoding the Epigenome: Comparative Analysis of Uterine Leiomyosarcoma and Leiomyoma.解读表观基因组:子宫平滑肌肉瘤与平滑肌瘤的比较分析
Cancers (Basel). 2025 Aug 9;17(16):2610. doi: 10.3390/cancers17162610.
2
MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma.MiR-221、miR-320a、miR133a和miR-133b作为平滑肌肉瘤潜在的生物标志物。
Front Oncol. 2025 Jun 20;15:1577859. doi: 10.3389/fonc.2025.1577859. eCollection 2025.
3
Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls.

本文引用的文献

1
miR-497 Target Gene Regulatory Network in Angiosarcoma.血管肉瘤中 miR-497 的靶基因调控网络。
Mol Cancer Res. 2024 Sep 4;22(9):879-890. doi: 10.1158/1541-7786.MCR-23-1075.
2
Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies.滑膜肉瘤:特征、挑战及不断发展的治疗策略
ESMO Open. 2023 Oct;8(5):101618. doi: 10.1016/j.esmoop.2023.101618. Epub 2023 Aug 23.
3
The Role of MicroRNAs in Uterine Leiomyosarcoma Diagnosis and Treatment.微小RNA在子宫平滑肌肉瘤诊断与治疗中的作用
肺泡横纹肌肉瘤的分子靶点:进展与陷阱的叙述性综述
Int J Mol Sci. 2025 May 28;26(11):5204. doi: 10.3390/ijms26115204.
4
The Double Life of microRNAs in Bone Sarcomas: Oncogenic Drivers and Tumor Suppressors.微小RNA在骨肉瘤中的双重作用:致癌驱动因素和肿瘤抑制因子
Int J Mol Sci. 2025 May 17;26(10):4814. doi: 10.3390/ijms26104814.
5
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma.PI3K-Akt-mTOR在横纹肌肉瘤中的新兴作用及临床意义
Biomolecules. 2025 Feb 25;15(3):334. doi: 10.3390/biom15030334.
6
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target.解析MYC在肉瘤中的作用及其作为有前景治疗靶点的潜力
Int J Mol Sci. 2025 Feb 25;26(5):1973. doi: 10.3390/ijms26051973.
Cancers (Basel). 2023 Apr 23;15(9):2420. doi: 10.3390/cancers15092420.
4
Therapeutic advances in leiomyosarcoma.平滑肌肉瘤的治疗进展
Front Oncol. 2023 Mar 8;13:1149106. doi: 10.3389/fonc.2023.1149106. eCollection 2023.
5
Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.未分化多形性肉瘤/肌纤维肉瘤的当前研究与管理
Front Genet. 2023 Feb 16;14:1109491. doi: 10.3389/fgene.2023.1109491. eCollection 2023.
6
MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas.微小RNA在软组织肉瘤发病机制、预后及治疗耐药预测中的作用
Cancers (Basel). 2023 Jan 18;15(3):577. doi: 10.3390/cancers15030577.
7
The Immune Contexture of Liposarcoma and Its Clinical Implications.脂肪肉瘤的免疫微环境及其临床意义。
Cancers (Basel). 2022 Sep 21;14(19):4578. doi: 10.3390/cancers14194578.
8
From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer.从分子机制到治疗:了解癌症中的 microRNA-21。
Cells. 2022 Sep 7;11(18):2791. doi: 10.3390/cells11182791.
9
miRNAs as Biomarkers and Possible Therapeutic Strategies in Synovial Sarcoma.微小RNA作为滑膜肉瘤的生物标志物及可能的治疗策略
Front Pharmacol. 2022 Aug 8;13:881007. doi: 10.3389/fphar.2022.881007. eCollection 2022.
10
MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms.微小RNA-21通过不同机制发挥免疫抑制和促进转移的作用。
Oncogenesis. 2022 Jul 11;11(1):38. doi: 10.1038/s41389-022-00413-7.